Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Australian Centre for NanoMedicine, University of New South Wales, Sydney, NSW, 2052, Australia.
Anal Bioanal Chem. 2021 Apr;413(9):2311-2330. doi: 10.1007/s00216-020-03046-0. Epub 2020 Nov 20.
The current global fight against coronavirus disease (COVID-19) to flatten the transmission curve is put forth by the World Health Organization (WHO) as there is no immediate diagnosis or cure for COVID-19 so far. In order to stop the spread, researchers worldwide are working around the clock aiming to develop reliable tools for early diagnosis of severe acute respiratory syndrome (SARS-CoV-2) understanding the infection path and mechanisms. Currently, nucleic acid-based molecular diagnosis (real-time reverse transcription polymerase chain reaction (RT-PCR) test) is considered the gold standard for early diagnosis of SARS-CoV-2. Antibody-based serology detection is ineffective for the purpose of early diagnosis, but a potential tool for serosurveys, providing people with immune certificates for clearance from COVID-19 infection. Meanwhile, there are various blooming methods developed these days. In this review, we summarise different types of coronavirus discovered which can be transmitted between human beings. Methods used for diagnosis of the discovered human coronavirus (SARS, MERS, COVID-19) including nucleic acid detection, gene sequencing, antibody detection, antigen detection, and clinical diagnosis are presented. Their merits, demerits and prospects are discussed which can help the researchers to develop new generation of advanced diagnostic tools for accurate and effective control of human coronavirus transmission in the communities and hospitals.
当前,全球正在共同努力抗击新型冠状病毒病(COVID-19),以遏制其传播。世界卫生组织(WHO)提出这一举措,是因为目前尚无针对 COVID-19 的即时诊断或治疗方法。为了阻止病毒传播,世界各地的研究人员正在争分夺秒地开发可靠的工具,以了解感染途径和机制,从而实现对严重急性呼吸综合征(SARS-CoV-2)的早期诊断。目前,基于核酸的分子诊断(实时逆转录聚合酶链反应(RT-PCR)检测)被认为是 SARS-CoV-2 早期诊断的金标准。基于抗体的血清学检测对于早期诊断效果不佳,但它是血清学调查的一种潜在工具,可以为从 COVID-19 感染中清除的人提供免疫证书。同时,如今也涌现出了各种检测方法。在这篇综述中,我们总结了不同类型的可在人际间传播的冠状病毒。介绍了已发现的人类冠状病毒(SARS、MERS、COVID-19)的诊断方法,包括核酸检测、基因测序、抗体检测、抗原检测和临床诊断。并对它们的优缺点和前景进行了讨论,这有助于研究人员开发新一代先进的诊断工具,以在社区和医院中准确有效地控制人类冠状病毒的传播。